Contract 75A50323C00005
Mckesson Corporation · Department Of Health And Human Services · September 29, 2023
Mckesson Corporation was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 29, 2023 for $5.84 million (current value) of work in pharmaceutical preparation manufacturing. Performance is in Irving, TX. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $5.84 million.
Contract details
- PIID
- 75A50323C00005
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Irving, TX
- First action
- September 29, 2023
Description
TO SUSTAIN 266,000 EACHES/VIALS OF PENICILLIN G POTASSIUM 20MU, NDC 7086-00127-51
Modification timeline
-
September 29, 2023Mod P00001 · Other Administrative Action$5.84M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50323C00005?
Contract 75A50323C00005 is a federal contract awarded to Mckesson Corporation by Department Of Health And Human Services on September 29, 2023 for $5.84 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50323C00005?
Mckesson Corporation won contract 75A50323C00005 from Department Of Health And Human Services.
How much is contract 75A50323C00005 worth?
Contract 75A50323C00005 has obligated $0 to date but carries a potential ceiling of $5.84 million if fully funded and all options are exercised.